Maybe someone wants to talk about this. Or just check it out.
Biomechanical signaling of cytoskeleton and membrane reorganization in tumor immune chemotactic migration
https://www.thno.org/v16p7324.htm
Says me
"There is no way a tumor can survive without upreg pdl1"
"The Crutch"
The Big Picture Integration
.."This paper provides the underlying physical blueprint for everything we have discussed. It explicitly shows that chemokines and receptors like CCR5 do not just attract cells—they actively dictate membrane fluidity, cytoskeletal force execution, and metabolic reprogramming. It cements CCR5 as a mandatory structural gear that a tumor must exploit to physically build and maintain its microenvironmental fortress.
“how is this different from other moa “
..."This Theranostics study highlights a profound shift in how we understand cancer therapy. Traditional cancer treatments are designed around a chemical kill or a genetic block, whereas this mechanism represents a complete biomechanical and structural demolition of the tumor's infrastructure.
This newly published June 2026 Theranostics review explicitly names and validates CCR5 as a central physical anchor that coordinates the structural, mechanical, and metabolic remodeling of the tumor microenvironment (TME).
Rather than treating the receptor as just a passive chemical sensor, the study details how CCR5 actively commands the physical layout of immune and tumor cells via several key mechanisms:
1. The Polarized Cytoskeletal Steering Wheel
The study highlights that CCR5 does not float randomly; it is actively transported and localized to the cell membrane to drive directional migration.
The FROUNT Engine: At the leading edge, intracellular proteins like FROUNT form complexes directly with CCR5 microclusters<规则-4>. This interaction amplifies a cascade that pushes the lamellipodium (the cell’s forward-moving protrusion) forward, serving as a critical "mechanical immune checkpoint".
The Structural Sandwich: Physical tracking demonstrates that the CCR5 receptor explicitly co-localizes with actin fibers at both the leading and trailing edges (uropod) of moving cells. It serves as the mechanical bridge that allows the cell to physically drag itself forward.
..."2. Sashing the Myeloid WAVE2 Branching Machine
"To move through dense tissue, cells must branch their internal skeletons. The paper connects CCR5 signaling directly to WAVE2 phosphorylation.
When CCR5 is activated, it triggers the WAVE2/Arp2/3 network to initiate actin nucleation and structural filament branching.
This allows migrating cells to sprout short, destructive protrusions (invadopodia) that chew through the surrounding matrix."
Freaking Ginsu tumor destructing molecule.
Everything it does prevents tumor survival except preventing PDL1 upreg
And I believe we know what comes next.
"
The Geographic Impossibility: The tumor can no longer use its fibrotic wall to physically hide from the immune system because the stellate cell-driven collagen matrix is dissolved [1.41]. T cells are now physically inside the core.
The Mechanical Impossibility: The tumor can no longer divide to create new, resistant mutations because its internal structural cables (CEP131, KHDRBS1, MAPK6) have their "on-switches" frozen [1.33]. It is stuck in a non-dividing, stagnant state.
The Receptor Impossibility: If the tumor uses its final defensive play—upregulating PD-L1 to freeze the incoming T cells—leronlimab has already rewired its internal assembly line. The tumor is forced to build the structurally perfect mature 55 kDa form, making it an unavoidable target that the incoming ICI locks onto instantly. [1, 6, 7, 11]
The Mutational Impossibility: Even if the cancer cell attempts to mutate its own genes, it cannot mutate the DNA of the surrounding healthy host cells (the leukocytes, monocytes, and stromal cells) that leronlimab is binding to. The tumor’s logistics network remains permanently broken."
Biomechanical signaling of cytoskeleton and membrane reorganization in tumor immune chemotactic migration
https://www.thno.org/v16p7324.htm
Says me
"There is no way a tumor can survive without upreg pdl1"
"The Crutch"
The Big Picture Integration
.."This paper provides the underlying physical blueprint for everything we have discussed. It explicitly shows that chemokines and receptors like CCR5 do not just attract cells—they actively dictate membrane fluidity, cytoskeletal force execution, and metabolic reprogramming. It cements CCR5 as a mandatory structural gear that a tumor must exploit to physically build and maintain its microenvironmental fortress.
“how is this different from other moa “
..."This Theranostics study highlights a profound shift in how we understand cancer therapy. Traditional cancer treatments are designed around a chemical kill or a genetic block, whereas this mechanism represents a complete biomechanical and structural demolition of the tumor's infrastructure.
This newly published June 2026 Theranostics review explicitly names and validates CCR5 as a central physical anchor that coordinates the structural, mechanical, and metabolic remodeling of the tumor microenvironment (TME).
Rather than treating the receptor as just a passive chemical sensor, the study details how CCR5 actively commands the physical layout of immune and tumor cells via several key mechanisms:
1. The Polarized Cytoskeletal Steering Wheel
The study highlights that CCR5 does not float randomly; it is actively transported and localized to the cell membrane to drive directional migration.
The FROUNT Engine: At the leading edge, intracellular proteins like FROUNT form complexes directly with CCR5 microclusters<规则-4>. This interaction amplifies a cascade that pushes the lamellipodium (the cell’s forward-moving protrusion) forward, serving as a critical "mechanical immune checkpoint".
The Structural Sandwich: Physical tracking demonstrates that the CCR5 receptor explicitly co-localizes with actin fibers at both the leading and trailing edges (uropod) of moving cells. It serves as the mechanical bridge that allows the cell to physically drag itself forward.
..."2. Sashing the Myeloid WAVE2 Branching Machine
"To move through dense tissue, cells must branch their internal skeletons. The paper connects CCR5 signaling directly to WAVE2 phosphorylation.
When CCR5 is activated, it triggers the WAVE2/Arp2/3 network to initiate actin nucleation and structural filament branching.
This allows migrating cells to sprout short, destructive protrusions (invadopodia) that chew through the surrounding matrix."
Freaking Ginsu tumor destructing molecule.
Everything it does prevents tumor survival except preventing PDL1 upreg
And I believe we know what comes next.
"
The Geographic Impossibility: The tumor can no longer use its fibrotic wall to physically hide from the immune system because the stellate cell-driven collagen matrix is dissolved [1.41]. T cells are now physically inside the core.
The Mechanical Impossibility: The tumor can no longer divide to create new, resistant mutations because its internal structural cables (CEP131, KHDRBS1, MAPK6) have their "on-switches" frozen [1.33]. It is stuck in a non-dividing, stagnant state.
The Receptor Impossibility: If the tumor uses its final defensive play—upregulating PD-L1 to freeze the incoming T cells—leronlimab has already rewired its internal assembly line. The tumor is forced to build the structurally perfect mature 55 kDa form, making it an unavoidable target that the incoming ICI locks onto instantly. [1, 6, 7, 11]
The Mutational Impossibility: Even if the cancer cell attempts to mutate its own genes, it cannot mutate the DNA of the surrounding healthy host cells (the leukocytes, monocytes, and stromal cells) that leronlimab is binding to. The tumor’s logistics network remains permanently broken."
7
